Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
Browse the world's most comprehensive archive of hedge fund manager letters. Access primary source research from leading institutional managers, sorted by reporting period.
Outperforming the Russell 2000 Value Index as gains in Zebra Technologies and biopharma suppliers offset consumer headwinds, while completely exiting Leslie's Inc. and spin-off shares to concentrate in top ideas.
Full Quick Take
Outperforming the Russell 2000 Value Index as gains in Zebra Technologies and biopharma suppliers offset consumer headwinds, while completely exiting Leslie's Inc. and spin-off shares to concentrate in top ideas.
Despite Q4 underperformance driven by sharp style headwinds, the fund remains committed to its high-quality growth strategy, benefiting from AI-exposed hardware leaders and anticipating pipeline catalysts in healthcare.
Full Quick Take
Despite Q4 underperformance driven by sharp style headwinds, the fund remains committed to its high-quality growth strategy, benefiting from AI-exposed hardware leaders and anticipating pipeline catalysts in healthcare.